These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19429085)

  • 21. Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease.
    Sutherland GT; Siebert GA; Newman JR; Silburn PA; Boyle RS; O'Sullivan JD; Mellick GD
    Mov Disord; 2009 Feb; 24(3):449-52. PubMed ID: 19117363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.
    Saini P; Rudakou U; Yu E; Ruskey JA; Asayesh F; Laurent SB; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Espay AJ; Rouleau GA; Alcalay RN; Fon EA; Postuma RB; Gan-Or Z
    Neurobiol Aging; 2021 Apr; 100():119.e7-119.e13. PubMed ID: 33239198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic analysis of indel markers in three loci associated with Parkinson's disease.
    Huo Z; Luo X; Zhan X; Chu Q; Xu Q; Yao J; Pang H
    PLoS One; 2017; 12(9):e0184269. PubMed ID: 28873462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analyses of seven
    Dai D; Wang Y; Zhou X; Tao J; Jiang D; Zhou H; Jiang Y; Pan G; Ru P; Ji H; Li J; Zhang Y; Yin H; Xu M; Duan S
    Biomed Rep; 2014 Nov; 2(6):886-892. PubMed ID: 25279164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease.
    Parboosingh JS; Rousseau M; Rogan F; Amit Z; Chertkow H; Johnson WG; Manganaro F; Schipper HN; Curran TJ; Stoessl J
    Arch Neurol; 1995 Dec; 52(12):1160-3. PubMed ID: 7492289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The causative gene of Parkinsonism and its medical treatment strategy].
    Inden M
    Yakugaku Zasshi; 2014; 134(12):1253-8. PubMed ID: 25452235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
    Gagliardi M; Iannello G; Colica C; Annesi G; Quattrone A
    Neurobiol Aging; 2017 Feb; 50():169.e5-169.e6. PubMed ID: 27839905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of Parkinson's disease: a review of SNCA and LRRK2.
    Konno T; Siuda J; Wszolek ZK
    Wiad Lek; 2016; 69(3 Pt 1):328-32. PubMed ID: 27486710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of Parkinson's disease genetics.
    Lorincz MT
    Semin Neurol; 2006 Nov; 26(5):492-8. PubMed ID: 17048150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G309D and W437OPA PINK1 mutations in Caucasian Parkinson's disease patients.
    Deng H; Le WD; Zhang X; Pan TH; Jankovic J
    Acta Neurol Scand; 2005 Jun; 111(6):351-2. PubMed ID: 15876334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease.
    Vilariño-Güell C; Ross OA; Soto AI; Farrer MJ; Haugarvoll K; Aasly JO; Uitti RJ; Wszolek ZK
    Mov Disord; 2009 Mar; 24(4):619-20. PubMed ID: 19133664
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening of ferritin light polypeptide 460-461InsA mutation in Parkinson's disease patients in North America.
    Chen R; Langston JW; Chan P
    Neurosci Lett; 2002 Dec; 335(2):144-6. PubMed ID: 12459518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
    Myhre R; Klungland H; Farrer MJ; Aasly JO
    BMC Med Genet; 2008 Mar; 9():19. PubMed ID: 18366718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians.
    Sudhaman S; Behari M; Govindappa ST; Muthane UB; Juyal RC; Thelma BK
    Neurobiol Aging; 2013 Oct; 34(10):2442.e1-3. PubMed ID: 23726718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is GIGYF2 the defective gene at the PARK11 locus?
    Bonifati V
    Curr Neurol Neurosci Rep; 2009 May; 9(3):185-7. PubMed ID: 19348706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Panel Sequencing Identifies Novel Pathogenic Mutations in Moroccan Patients with Familial Parkinson Disease.
    Smaili I; Tesson C; Regragui W; Bertrand H; Rahmani M; Bouslam N; Benomar A; Brice A; Lesage S; Bouhouche A
    J Mol Neurosci; 2021 Jan; 71(1):142-152. PubMed ID: 32557143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy.
    Gagliardi M; Annesi G; Tarantino P; Nicoletti G; Quattrone A
    Neurobiol Aging; 2014 Oct; 35(10):2422.e1-2. PubMed ID: 24854799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.
    Fung HC; Chen CM; Hardy J; Singleton AB; Wu YR
    BMC Neurol; 2006 Dec; 6():47. PubMed ID: 17187665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.